Intelligent Bio Solutions Inc./$INBS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
Ticker
$INBS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
50
ISIN
US36151G6008
Website
INBS Metrics
BasicAdvanced
$8.9M
-
-$2.40
4.63
-
Price and volume
Market cap
$8.9M
Beta
4.63
52-week high
$2.50
52-week low
$1.10
Average daily volume
96K
Financial strength
Current ratio
1.119
Quick ratio
0.841
Long term debt to equity
0.075
Total debt to equity
10.34
Interest coverage (TTM)
-98.26%
Management effectiveness
Return on assets (TTM)
-48.62%
Return on equity (TTM)
-129.19%
Valuation
Price to revenue (TTM)
1.882
Price to book
1.71
Price to tangible book (TTM)
6.69
Price to free cash flow (TTM)
-0.521
Growth
Revenue change (TTM)
3.87%
Earnings per share change (TTM)
-79.49%
3-year revenue growth (CAGR)
22.24%
3-year earnings per share growth (CAGR)
-72.91%
INBS News
AllArticlesVideos
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
GlobeNewsWire·1 day ago
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
GlobeNewsWire·4 days ago
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Intelligent Bio Solutions Inc. stock?
Intelligent Bio Solutions Inc. (INBS) has a market cap of $8.9M as of May 23, 2025.
What is the P/E ratio for Intelligent Bio Solutions Inc. stock?
The price to earnings (P/E) ratio for Intelligent Bio Solutions Inc. (INBS) stock is 0 as of May 23, 2025.
Does Intelligent Bio Solutions Inc. stock pay dividends?
No, Intelligent Bio Solutions Inc. (INBS) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Intelligent Bio Solutions Inc. dividend payment date?
Intelligent Bio Solutions Inc. (INBS) stock does not pay dividends to its shareholders.
What is the beta indicator for Intelligent Bio Solutions Inc.?
Intelligent Bio Solutions Inc. (INBS) has a beta rating of 4.63. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.